The neurochemical mechanism of rebound psychosis in Parkinson's disease (multiple letters) [6]

Movement Disorders

Volumn 20, Issue 4, 2005, Pages 515-

  Papapetropoulos, Spiridon ^a   Mash, Deborah C ^a   Fernandez, Hubert H ^b   Okun, Michael S ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; QUETIAPINE; SEROTONIN 2 RECEPTOR;

CHRONIC DRUG ADMINISTRATION; DEGENERATIVE DISEASE; DOPAMINERGIC ACTIVITY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RECEPTOR BINDING; DRUG WITHDRAWAL; HUMAN; LETTER; LIMBIC CORTEX; LIMBIC SYSTEM; NEUROCHEMISTRY; NEUROTRANSMISSION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOSIS; RECURRENT DISEASE;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; DIBENZOTHIAZEPINES; HUMANS; PARKINSON DISEASE; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS;

EID: 20344381824     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20438     Document Type: Letter

References (0)